Janitzek, Christoph M.
Peabody, Julianne
Thrane, Susan
H. R. Carlsen, Philip
G. Theander, Thor
Salanti, Ali
Chackerian, Bryce
A. Nielsen, Morten http://orcid.org/0000-0003-2668-4992
Sander, Adam F.
Funding for this research was provided by:
Bill and Melinda Gates Foundation (Global Grand Challenges, Combinatorial Vaccine to Protect Women Against Disease, Global Grand Challenges, Combinatorial Vaccine to Protect Women Against Disease, Global Grand Challenges, Combinatorial Vaccine to Protect Women Against Disease, Global Grand Challenges, Combinatorial Vaccine to Protect Women Against Disease, Global Grand Challenges, Combinatorial Vaccine to Protect Women Against Disease, Global Grand Challenges, Combinatorial Vaccine to Protect Women Against Disease, Global Grand Challenges, Combinatorial Vaccine to Protect Women Against Disease)
Ministry of Foreign Affairs of Denmark | Danish International Development Agency (12-055KU, 12-055KU, 12-055KU, 12-055KU, 12-055KU, 12-055KU, 12-055KU)
EC | EC Seventh Framework Programm | FP7 Health (304815, 304815, 304815, 304815, 304815, 304815, 304815)
EC | Eurostars (11019, 11019, 11019, 11019, 11019, 11019, 11019)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19 AI13187, U19 AI13187)
Article History
Received: 3 December 2018
Accepted: 8 March 2019
First Online: 27 March 2019
Competing Interests
: C.M.J., S.T., T.G.T., A.S., M.A.N. and A.F.S. are inventors on a patent application concerning the VLP-display technology (WO2016112921 A1) licensed to AdaptVac. S.T. and A.F.S. are currently partially employed in AdaptVac. J.P., P.R.C. and B.C. declare no conflict of interest.